News and blog

New Research Professor MSO in Vaccine Adjuvants at Statens Serum Institut Copenhagen, Denmark

Pharma

PRESS RELEASE: Croda Pharma is happy to announce that Dennis Christensen, PhD, Head of Global Research and Development for Vaccine Adjuvant Systems, has been appointed as a part-time Research...

Surfactants in biopharmaceutical development

Pharma

Discover insights from our industry experts

Croda Pharma launches a new bioprocessing solution for shear stress in mammalian cell culture

Pharma

Croda Pharma has announced the launch of Super Refined™ Poloxamer 188, an innovative bioprocessing solution developed to meet the increasing demands of biopharmaceutical development.

Announcing Avanti Research - a Croda brand

Pharma

Avanti Polar Lipids, a global leader in lipids, has announced its renewed offering for researchers and its transformation to Avanti Research.

The Oral Hygiene market is evolving

Pharma

Growth in the oral hygiene market is mainly focused around two main categories: toothpastes and mouthwashes. The global oral hygiene market size was valued at USD 31.7 billion in 2020 and is expected...

EXCLUSIVE WHITEPAPER: Next-generation Triton™ X-100 replacements for pharmaceutical bioprocessing

Pharma

Triton™ X-100 (tert-octyl phenyl ethoxylate) is used extensively in the manufacture of biologics, plasma-derived products and cell and gene therapies (CGTs). This non-ionic detergent is used because...

Veterinary vaccines - solutions for an ongoing challenge...

Pharma

Growth in the veterinary pharmaceutical industry continues to be driven by increasing pet ownership globally and the rising demand for veterinary vaccines to prevent the risk of zoonotic diseases in...

QbD Formulation Development

Pharma

Formulation development is a pivotal stage in the life cycle of a therapeutic drug product, it can be the make or break of it. The goal of formulation development is to convert active substance (drug...

Targeted lipid nanoparticles in Nucleic Acid Delivery

Pharma

Targeted lipid nanoparticles (tLNPs) enhance the precision and efficacy of delivering a variety of therapeutic agents including nucleic acids to specific tissues and cell populations, thereby...

Croda joins CGT Catapult consortium to improve AAV formulation

Pharma

The Cell and Gene Therapy Catapult (CGT Catapult) has established a cross-industry consortium to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation.

Synthesis, characterisation and degradation of polysorbates in biopharmaceuticals

Pharma

Polysorbates are essential in biologics delivery, serving as crucial emulsifiers and stabilisers for biopharmaceuticals. They enhance solubility, improve bioavailability, and protect proteins from...

woman applying cream to upper arm and back

Product Spotlight - Crodamol™ CCC Pharma

Pharma

Crodamol™ CCC Pharma is a mild, non-irritating liquid emollient, ideal for sensitive site applications. The excipient can contribute to many benefits for various topical formulations.

Lipid Leaders: Söhnke Voss

Pharma

In this Lipid Leaders interview, we speak to Söhnke Voss, PhD. Söhnke is a lipids expert with over 25 years’ experience in the pharmaceutical industry. Keep reading to learn more about lipids and the...

Protein Delivery Leaders: Andrew Bright

Pharma

In this Protein Delivery Leaders interview, we speak to Andrew Bright, PhD. Keep reading to learn more about breakthroughs in protein delivery and key challenges faced in biologic formulations.

Croda Pharma wins ‘Best Production/Process Development’ Award at the 17th annual Vaccine Industry Excellence awards

Pharma

Croda Pharma has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived...

Partnership agreement between Croda and AAHI to drive innovation in vaccine development

Pharma

19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...

Croda Foundation announces it has sustainably improved the lives of 22.8 million people – exceeding its 2030 target.

Pharma

Croda Foundation announces it has sustainably improved the lives of 22.8 million people –exceeding its 2030 target.

Product Spotlight - Super Refined PEG 400

Pharma

Super Refined PEG 400 is a highly purified solubiliser is an exemplary excipient in both small molecule and protein formulations containing the most sensitive APIs for treatments of a range of...